Stay updated on Efficacy of Pexidartinib in TGCT Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.

Latest updates to the Efficacy of Pexidartinib in TGCT Clinical Trial page
- Check6 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check13 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The clinical trial details remain inaccessible on the page.SummaryDifference1%

- Check20 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2 while the page remained a 403 error page.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating restricted access to the study record. The header and footer remain visible, while the main content is replaced with an access-denied message.SummaryDifference18%

- Check69 days agoChange DetectedThe page's revision indicator was updated from v3.6.5 to v3.6.6, reflecting a minor version bump in the site's metadata.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Pexidartinib in TGCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.